Travere Therapeutics Inc
(TVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 175,338 | 164,246 | 154,937 | 133,591 | 99,892 |
| Cost of Goods | 5,234 | 5,527 | 3,605 | 4,554 | 2,185 |
| Gross Profit | 170,104 | 158,719 | 151,332 | 129,037 | 97,707 |
| Operating Expenses | 307,699 | 239,286 | 205,728 | 187,805 | 148,640 |
| Operating Income | -137,361 | -80,040 | -53,791 | -58,214 | -50,748 |
| Interest Expense | 18,828 | 9,810 | 4,422 | 4,734 | 8,348 |
| Other Income | 9,741 | -12,017 | -150 | 5,366 | 164,563 |
| Pre-tax Income | -146,448 | -101,867 | -58,363 | -57,582 | 105,467 |
| Income Tax | -21 | 811 | 1,368 | -9,679 | -11,770 |
| Net Income Continuous | -146,427 | -102,678 | -59,731 | -47,903 | 117,237 |
| Net Income | $-146,427 | $-102,678 | $-59,731 | $-47,903 | $117,237 |
| EPS Basic Total Ops | -3.46 | -2.54 | -1.54 | -1.29 | 3.49 |
| EPS Basic Continuous Ops | -3.46 | -2.54 | -1.54 | -1.29 | 3.49 |
| EPS Diluted Total Ops | -3.46 | -2.54 | -1.54 | -1.29 | 3.17 |
| EPS Diluted Continuous Ops | -3.46 | -2.54 | -1.54 | -1.25 | 3.12 |
| EPS Diluted Before Non-Recurring Items | -3.46 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-82,338 | $-57,592 | $-33,993 | $-40,326 | $-30,908 |